Cargando…

Statin Use and Markers of Immunity in the Doetinchem Cohort Study

It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, i...

Descripción completa

Detalles Bibliográficos
Autores principales: De Jong, Hilda J.I., Damoiseaux, Jan G.M.C., Vandebriel, Rob J., Souverein, Patrick C., Gremmer, Eric R., Wolfs, Mia, Klungel, Olaf H., Van Loveren, Henk, Cohen Tervaert, Jan Willem, Verschuren, W.M. Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797719/
https://www.ncbi.nlm.nih.gov/pubmed/24147031
http://dx.doi.org/10.1371/journal.pone.0077587
_version_ 1782287653105827840
author De Jong, Hilda J.I.
Damoiseaux, Jan G.M.C.
Vandebriel, Rob J.
Souverein, Patrick C.
Gremmer, Eric R.
Wolfs, Mia
Klungel, Olaf H.
Van Loveren, Henk
Cohen Tervaert, Jan Willem
Verschuren, W.M. Monique
author_facet De Jong, Hilda J.I.
Damoiseaux, Jan G.M.C.
Vandebriel, Rob J.
Souverein, Patrick C.
Gremmer, Eric R.
Wolfs, Mia
Klungel, Olaf H.
Van Loveren, Henk
Cohen Tervaert, Jan Willem
Verschuren, W.M. Monique
author_sort De Jong, Hilda J.I.
collection PubMed
description It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (>100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance.
format Online
Article
Text
id pubmed-3797719
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37977192013-10-21 Statin Use and Markers of Immunity in the Doetinchem Cohort Study De Jong, Hilda J.I. Damoiseaux, Jan G.M.C. Vandebriel, Rob J. Souverein, Patrick C. Gremmer, Eric R. Wolfs, Mia Klungel, Olaf H. Van Loveren, Henk Cohen Tervaert, Jan Willem Verschuren, W.M. Monique PLoS One Research Article It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (>100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance. Public Library of Science 2013-10-16 /pmc/articles/PMC3797719/ /pubmed/24147031 http://dx.doi.org/10.1371/journal.pone.0077587 Text en © 2013 De Jong et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
De Jong, Hilda J.I.
Damoiseaux, Jan G.M.C.
Vandebriel, Rob J.
Souverein, Patrick C.
Gremmer, Eric R.
Wolfs, Mia
Klungel, Olaf H.
Van Loveren, Henk
Cohen Tervaert, Jan Willem
Verschuren, W.M. Monique
Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title_full Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title_fullStr Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title_full_unstemmed Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title_short Statin Use and Markers of Immunity in the Doetinchem Cohort Study
title_sort statin use and markers of immunity in the doetinchem cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797719/
https://www.ncbi.nlm.nih.gov/pubmed/24147031
http://dx.doi.org/10.1371/journal.pone.0077587
work_keys_str_mv AT dejonghildaji statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT damoiseauxjangmc statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT vandebrielrobj statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT souvereinpatrickc statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT gremmerericr statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT wolfsmia statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT klungelolafh statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT vanloverenhenk statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT cohentervaertjanwillem statinuseandmarkersofimmunityinthedoetinchemcohortstudy
AT verschurenwmmonique statinuseandmarkersofimmunityinthedoetinchemcohortstudy